Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
05/2010
05/26/2010EP2084183B1 Pegylated pth as pth receptor modulators and uses thereof
05/26/2010EP1861400B1 Crystal forms of an imidazole derivative
05/26/2010EP1461325B1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
05/26/2010EP1448602B1 Modified anti-tnf alpha antibody
05/26/2010EP1424998B1 Synthesis and use of reagents for improved dna lipofection and/or slow release prodrug and drug therapies
05/26/2010EP1307225B1 Antagonists of cd30 or cd30l for use in treating auto-immune and chronic inflammatory conditions
05/26/2010CN1972931B Drug for treating or preventing duplication of hypertension with serum hyperuricemia and/or hypercholesterolemia
05/26/2010CN1969965B Ointment for treating bone injuries
05/26/2010CN1951483B Hybrid safflower oil and preparation method thereof
05/26/2010CN1931245B Medicine for treating gouty arthritis and its preparation process and application
05/26/2010CN1922183B Nitrogenous fused heteroaromatic ring derivative
05/26/2010CN1899401B Three ingredient body comfort liquid
05/26/2010CN1875997B Application of sundew in pharmaceutical preparation
05/26/2010CN1856478B Bicyclic imino acid derivatives as inhibitors of matrix metalloproteinases
05/26/2010CN1820011B Use of rapamycin and rapamycin derivatives for the treatment of bone loss
05/26/2010CN1690057B Selenophen derivatives and their use for prevention and/or treatment of diseases relative to protein aging
05/26/2010CN1681811B Azolidinone-vinyl fused-benzene derivatives
05/26/2010CN1678744B Human antihuman interleukin-6 antibody and fragment of the antibody
05/26/2010CN1656073B Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
05/26/2010CN1655823B Topically applicable pharmaceutical preparation
05/26/2010CN1646138B Novel therapeutical use of agonist ligands specific to G2A receptor
05/26/2010CN101715344A Use of HDAC inhibitors for the treatment of bone destruction
05/26/2010CN101712964A Fusion protein for inhibiting formation of osteoclast and preparation method as well as pharmaceutical composition thereof
05/26/2010CN101712720A Human antibodies that bind human TNF alpha
05/26/2010CN101712679A Acylamide class compound, medicine composition, preparation method and application thereof
05/26/2010CN101711806A Medicine for treating rheumatoid arthritis and preparation method thereof
05/26/2010CN101711805A Medicine composition for treating rheumatoid arthritis and preparation thereof
05/26/2010CN101711786A Preparation used for relieving osteoarthropathy and enhancing immunity
05/26/2010CN101711784A Preparation method of serissa serissoide extractive
05/26/2010CN101711783A Medicated wine for treating hyperosteogeny and femoral head necrosis
05/26/2010CN101711773A Oral liquid for treating gout and preparation method thereof
05/26/2010CN101711768A Application of diosmin in manufacturing medicaments
05/26/2010CN101711751A Febuxostat dispersing tablet preparation and preparation method thereof
05/26/2010CN101711743A Febuxostat dry suspension and preparation method thereof
05/26/2010CN101711734A Chinese herbal medicine quick-acting nursing liquid for tightening skin and removing wrinkles
05/26/2010CN101204412B Compound traditional Chinese traditional medicine for osteoporosis
05/26/2010CN101181453B Chinese medicine preparation for curing orthopaedics sickness
05/26/2010CN101062233B Powdered medicine for coaptation and its preparing process
05/26/2010CN101062210B Chinese medicine for treating bone disease
05/26/2010CN101049352B Method for preparing short-pedicel aconite root of Chinese traditional medicine
05/26/2010CN101040927B Chinese traditional medicine compound took orally for treating ankylosing spondylitis
05/26/2010CN101040926B Chinese traditional medicine compound took orally for treating cervical spondylosis
05/26/2010CN101014699B Medium for the redifferentiation of dedifferentiated chondrocytes into chondrocytes
05/25/2010US7723503 nucleotide sequences or complements that encode polypeptides having omega-3 desaturase and delta-12 desaturase enzyme activity, used for making polyunsaturated fatty acids; additives for drugs, nutritional compositions, animal feeds, as well as other products such as cosmetics
05/25/2010US7723500 Containing unmethylated CpG dinucleotides; redirection of a Th2 response to a Th1 response; atopic diseases, dermatitis; booster vaccines
05/25/2010US7723499 polynucleotides that code for polypeptides comprising amino acid sequences that preferentially recognize and bind to angiopoietins
05/25/2010US7723490 Process for correction of a disulfide misfold in Fc molecules
05/25/2010US7723479 BSL3 polypeptides
05/25/2010US7723361 Kaposi's sarcoma; Crohn's disease; combination therapy with an epoxide hydrolase inhibitor
05/25/2010US7723344 Dipeptidyl peptidase inhibitors
05/25/2010US7723336 Fused heterocyclic compounds useful as kinase modulators
05/25/2010US7723022 Oligonucleotide containing activated lymphocytes; antibody therap y; skin disorders; antiallergens; respiratory system disorders
05/25/2010CA2439295C Carbamate compounds for use in preventing or treating neurodegenerative disorders
05/25/2010CA2403423C Tri-aryl-substituted-ethane pde4 inhibitors
05/25/2010CA2395461C Methods of modulating c-kit tyrosine kinase function with indolinone compounds
05/25/2010CA2375923C Devices and compounds for treating arterial restenosis
05/25/2010CA2362279C Connective tissue softening
05/25/2010CA2361573C Biodegradable glass compositions and methods for radiation therapy
05/25/2010CA2321920C 2-(2,6-dioxopiperidin-3-yl)isoindoline derivatives, their preparation and their use as inhibitors of inflammatory cytokines
05/25/2010CA2314156C Pyrrole substituted 2-indolinone protein kinase inhibitors
05/20/2010WO2010056877A2 Haloalkyl containing compounds as cysteine protease inhibitors
05/20/2010WO2010056741A2 Phenylacetic acid inhibitors of cyclooxygenase
05/20/2010WO2010056044A2 Novel compound acting as a vanilloid receptor antagonist, isomer or pharmaceutically acceptable salt thereof, and pharmaceutical composition containing same
05/20/2010WO2010054438A1 Aryl di-substituted propenone compounds
05/20/2010WO2010020647A3 New method for identifying compounds useful for treating and/or preventing disease-associated with bone loss
05/20/2010WO2010011857A3 Parenteral administration of a glucosamine
05/20/2010WO2009152084A3 Adipose tissue-derived stem cells for veterinary use
05/20/2010US20100125101 Immunostimulatory nucleic acid molecules
05/20/2010US20100125080 Compounds for inflammation and immune-related uses
05/20/2010US20100125074 Thieno-[2,3-d]Pyrimidine and Thieno-Pyridazine Compounds and Methods of Use
05/20/2010US20100124570 Highly resilient copolymer with shape recovery force and flexibility and the use thereof for the repair of articular cartilage defects
05/20/2010US20100124563 Biomatrix Composition and Methods of Biomatrix Seeding
05/20/2010US20100124535 Aerosol Dispersions of Particles with Active Pharmaceutical Ingredients
05/20/2010CA2743749A1 Haloalkyl containing compounds as cysteine protease inhibitors
05/20/2010CA2743661A1 Aryl di-substituted propenone compounds
05/20/2010CA2743146A1 Heteroaryl diamide compounds useful as mmp-13 inhibitors
05/19/2010EP2186894A1 Monoclonal antibody having neutralizing activity against mmp13
05/19/2010EP2186830A1 Polyethylene glycol modified interferon alpha 2b and preparation method and applicatioins thereof
05/19/2010EP2186407A1 Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells
05/19/2010EP2185556A1 Imidazopyridine analogs and their use as agonists of the wnt-beta-catenin cellular messaging system
05/19/2010EP2185537A1 Pyrimidine and pyridine derivatives and their pharmaceutical use and compositions
05/19/2010EP2185186A2 Compound and device for treating bone and/or cartilage defects
05/19/2010EP2185163A2 Method and compound for the treatment of articular diseases or articular pain, or for the treatment of skin for aesthetic or other purposes, and the method of preparation of the compound
05/19/2010EP2185144A2 Composition for prevention or treatment of bone metabolism disorder comprising d-pinitol as an active ingredient
05/19/2010EP1485380B1 Azolylaminoazines as inhibitors of protein kinases
05/19/2010EP1467995B1 Pyrrolopyrimidine a2b selective antagonist compounds, their synthesis and use
05/19/2010EP1371646B1 Aryl-substituted alicyclic compound and medical composition comprising the same
05/19/2010EP1365795B1 Use of the g-csf as additional treatment in the reconstruction of connective tissue
05/19/2010EP1292671B9 Method for obtaining characterised muscle-derived cell populations and uses
05/19/2010CN1961934B Method for preparing Chinese medicinal wine for treating humerus lateral epicondylitis
05/19/2010CN1939343B Bone-peptide sodium chloride injection and its making method
05/19/2010CN1927309B Traditional Chinese medicine composition detection method
05/19/2010CN101709089A Monoclonal antibody for resisting Cyr61 protein and application thereof
05/19/2010CN101709088A Monoclonal antibody for resisting Cyr61 protein and application thereof
05/19/2010CN101709078A immune-modulating peptide
05/19/2010CN101708329A Product preparation for medical leech and new application of medical leech
05/19/2010CN101708328A Pharmaceutical application of CYR61 protein
05/19/2010CN101708324A Plaster used for treating femoral head necrosis and preparation method thereof
05/19/2010CN101708321A Steaming-washing medicament for treating bone damage disease
05/19/2010CN101708297A Medicament for treating gout disease
1 ... 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 ... 820